Skip to main content
A

Auro Laboratories Ltd. — Investor Relations & Filings

Ticker · 530233 ISIN · INE292C01011 LEI · 335800X1NEIR7EEPQC63 BSE.NS Manufacturing
Filings indexed 0 across all filing types
Latest filing no filings yet
Country IN India
Listing BSE.NS 530233

About Auro Laboratories Ltd.

http://www.aurolabs.com

Auro Laboratories Ltd. specializes in the manufacturing of Active Pharmaceutical Ingredients (APIs) and pharmaceutical intermediates. The company primarily focuses on the production of anti-diabetic drugs, with Metformin Hydrochloride being its flagship product. Its manufacturing facilities are compliant with World Health Organization Good Manufacturing Practices (WHO-GMP) and ISO standards, ensuring high-quality output for global markets. Auro Laboratories maintains a strong emphasis on research and development to optimize production processes and expand its product portfolio, which includes various specialty chemicals and therapeutic agents. The company provides cost-effective pharmaceutical solutions through integrated manufacturing capabilities and rigorous quality assurance protocols.

Recent filings

No filings indexed yet

We are still gathering filings for Auro Laboratories Ltd.. .

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.